Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

NCT06850623 is registered in ClinicalTrials.gov with EXACT Therapeutics AS as lead sponsor.

NCT NCT06850623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06850623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
Lead sponsor
EXACT Therapeutics AS
Phase
Phase 2
Overall status
Recruiting
Start date
June 19, 2025
Completion date
July 15, 2027
Enrollment
25 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced pancreatic adenocarcinoma